User profiles for Rasha Abu-Eid

Rasha Abu Eid

University of Aberdeen
Verified email at abdn.ac.uk
Cited by 1579

Raman spectroscopy: Current applications in breast cancer diagnosis, challenges and future prospects

…, AM Shaaban, D Muirhead, R Abu-Eid… - British journal of …, 2022 - nature.com
Despite significant improvements in the way breast cancer is managed and treated, it continues
to persist as a leading cause of death worldwide. If detected and diagnosed early, when …

Assessment of self-medication of antibiotics in a Jordanian population

…, ZH Baqain, A Abu Karaky, R Abu Eid - Medical Principles and …, 2008 - karger.com
Objective: To assess the extent of self-medication with antibiotics (SMA) in a Jordanian
population, and to evaluate the sociodemographic factors affecting this behaviour. Subjects and …

Selective inhibition of regulatory T cells by targeting the PI3K–Akt pathway

R Abu-Eid, RN Samara, L Ozbun, MY Abdalla… - Cancer immunology …, 2014 - AACR
Despite the strides that immunotherapy has made in mediating tumor regression, the clinical
effects are often transient, and therefore more durable responses are still needed. The …

Mutant KRAS conversion of conventional T cells into regulatory T cells

S Zdanov, M Mandapathil, R Abu Eid… - Cancer immunology …, 2016 - AACR
Constitutive activation of the KRAS oncogene in human malignancies is associated with
aggressive tumor growth and poor prognosis. Similar to other oncogenes, KRAS acts in a cell-…

Differential PI3Kδ Signaling in CD4+ T-cell Subsets Enables Selective Targeting of T Regulatory Cells to Enhance Cancer Immunotherapy

S Ahmad, R Abu-Eid, R Shrimali, M Webb, V Verma… - Cancer research, 2017 - AACR
To modulate T-cell function for cancer therapy, one challenge is to selectively attenuate
regulatory but not conventional CD4 + T-cell subsets [regulatory T cell (Treg) and conventional T …

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)- LLO immunotherapy

M Mkrtichyan, N Chong, R Abu Eid, A Wallecha… - … for immunotherapy of …, 2013 - Springer
Background One of the significant tumor immune escape mechanisms and substantial barrier
for successful immunotherapy is tumor-mediated inhibition of immune response through …

Enhanced Therapeutic Efficacy and Memory of Tumor-Specific CD8 T Cells by Ex Vivo PI3K-δ Inhibition

R Abu Eid, S Ahmad, Y Lin, M Webb, Z Berrong… - Cancer Research, 2017 - AACR
Inhibition of specific Akt isoforms in CD8 + T cells promotes favored differentiation into memory
versus effector cells, the former of which are superior in mediating antitumor immunity. In …

Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients

R Abu-Eid, FJ Ward - Immunology letters, 2021 - Elsevier
Some COVID-19 patients suffer complications from anti-viral immune responses which can
lead to both a dangerous cytokine storm and development of blood-borne factors that render …

Age and the architecture of oral mucosa

R Abu Eid, F Sawair, G Landini, T Saku - Age, 2012 - Springer
Age changes affect the oral mucosa (the protective lining of the oral cavity), but few of these
have been studied objectively. The aim of this study was to quantitatively analyse a number …

Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review

…, J Saganty, P Liu, B Elsberger, R Abu-Eid… - The Lancet …, 2023 - thelancet.com
Although similar phenotypically, there is evidence that male and female breast cancer differ
in their molecular landscapes. In this systematic review, we consolidated all existing …